Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2006-8-2
pubmed:abstractText
The availability of human embryonic stem cells (hESCs) reflects their outstanding potential for research areas such as human developmental biology, teratology, and cell-based therapies. To allow their continuous growth as undifferentiated cells, isolation and culturing were traditionally conducted on mouse embryonic fibroblast feeder layers, using medium supplemented with fetal bovine serum. However, these conditions allow possible exposure of the cells to animal pathogens. Because both research and future clinical application require an animal-free and well-defined culture system for hESCs, these conventional conditions would prevent the use of hESCs in human therapy. This chapter describes optional culture conditions based on either animal-free or feeder-free culture methods for hESCs.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Blood Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Culture Media, http://linkedlifedata.com/resource/pubmed/chemical/Fibroblast Growth Factor 2, http://linkedlifedata.com/resource/pubmed/chemical/Fibronectins, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6, http://linkedlifedata.com/resource/pubmed/chemical/LIF protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Leukemia Inhibitory Factor, http://linkedlifedata.com/resource/pubmed/chemical/Lif protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/TGFB1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Tgfb1 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta, http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta1
pubmed:status
MEDLINE
pubmed:issn
1064-3745
pubmed:author
pubmed:issnType
Print
pubmed:volume
331
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
105-13
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16881512-Animals, pubmed-meshheading:16881512-Blood Proteins, pubmed-meshheading:16881512-Cell Culture Techniques, pubmed-meshheading:16881512-Cell Differentiation, pubmed-meshheading:16881512-Cell Division, pubmed-meshheading:16881512-Cell Line, pubmed-meshheading:16881512-Culture Media, pubmed-meshheading:16881512-Fibroblast Growth Factor 2, pubmed-meshheading:16881512-Fibroblasts, pubmed-meshheading:16881512-Fibronectins, pubmed-meshheading:16881512-Humans, pubmed-meshheading:16881512-Interleukin-6, pubmed-meshheading:16881512-Leukemia Inhibitory Factor, pubmed-meshheading:16881512-Mice, pubmed-meshheading:16881512-Pluripotent Stem Cells, pubmed-meshheading:16881512-Skin, pubmed-meshheading:16881512-Transforming Growth Factor beta, pubmed-meshheading:16881512-Transforming Growth Factor beta1
pubmed:year
2006
pubmed:articleTitle
Maintenance of human embryonic stem cells in animal serum- and feeder layer-free culture conditions.
pubmed:affiliation
Department of Obstetrics and Gynecology, Rambam Medical Centre, Faculty of Medicine, Technion, Haifa, Israel.
pubmed:publicationType
Journal Article